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Ol&?etives. We tested tke hypothesis tbat long-term betablocker treatment with bisoprolol prevents creatioe kinase (CK) aad lactate dehydrognase system changes that occur after chronic myocardial infarction.
l3ae&ad. The mechanism of the beneficiil e&t of betablocker therapy is still ~elear.
M&ho&. Sii gmups of rats were studied. Sham operated (sham) and hearts with &ate@ i& =anterior dtxending cownary PrteIy (myocardial infarction) were ontreatwl, treated early (begbming 30 q dn after in&rction) or treated late (beginning 14 days after inhrction). After 8 weeks be& were isolated sod b&r perfused isovolmnetrIcally. With a left ventrieldar balloon, me. cbanical &n&ion was recorded st ali ~nhioistolic pressure of 18 mm Hg. Biopsy samples of aoninhrcted left ventricular tissue were taken. Enzyme activities were rzasured spectrophtometrieally; isoenzymes were sepamted by agar gel electropboresi$ and total creatine levels were measured with bigb performance liioid homatqrapby.
lttwt&. Tbe decrease in left ventrhdar developed pressure in ~trestedhcarts(lU)-c9vs104i: §mmHg[megn+SE],pc 0.05, sham vs. q yocardiil infarction) after myocardial infarction
In recent large clinical trials, mortality was reduced by hetaadrenergic blocking agents in patients with heart failure resulting from dilated cardiomyopathy but not in patients with a history of myocardial infarction (1). In contrast, in patients treated for myocardial infarction with beta-blockers, benefit was related to cardiac dysfunction (2) . This apparent paradox remains unresolved and underlines our lack of understanding of the mechanisms of beta-blocker therapy in patients with chronic heart failure. Lowering heart rate may be one major From the Wiirzburg University, Winzhurg and ' Mannhcim/t!wdeltq Univer&y, Mannheim, Germany, and tBrigham and Women' s Hospital Boston, Mawachuac~~. Ibis study was suported by Gran$ SFB 355/A-3 and B-1 from dw Deutache Foischungxgemeinschaft, Bonn, Germany and by a grant from Merck AC, Darmstadt, Germany. Helena laboratories, Hariheim, Germany swxdiid the electrwhoresis eauimnent.
. wns pmmted by bisoprolol treatment. Early treamt was more e&dive tban late tkerapy in preventing CK and lactate debydrogenase system ckanges. Ia addition, in sbam harts, a 40% increase of creathe levels above normal levels was detected. m. Bisoprohd prevented changes in CK and lactate dekydrogenase systems tbat occur after myomrdii infarction. Tbeseobse-rvatioasmayberelatedtotkebeneh&le6ectsof long-tern behblocker treatment in patiwts with cbrooic myocardii inbrction.
(J Am cdl c.hiid 1996;27:487-93) beneficial effect (3-S); others may be a&rhythmic actions (6.7) or up-regulation of beta-receptor density (3.4) . Various studies on patients with heart failure showed a hemodynamic benefit of chronic beta-blocker treatment (8) . Beta-blockade m heart failure improved exercise capacity, left vzntricular ejection fraction, stroke and cardiac index ant arteriovenous oxygen difference. Myocardial oxygen consumption was unchanged despite the increase in cardiac mechanical, work, implying that beta-blocker therapy was energetically favqrable for the heart. However, data are inconclusive, and studies have been hampered by inhomogeneity qf diseases underlying heart failure and variation of therapeutic regimens. The dilated heart faces chronically increased wall strts (9) and energy demand. In an animal model of chronic myocardial infarction. we have previously shown that energy reserve of residual intact myocardium is impaired with substantial reductions of creatine phosphate, total creatine, total creatine kinase (CK) and mitochondrial CK isoenzyme (mito-CK) activity and a shift of lactate dehydrogenase isoenzymes towards anaerobic metabolism (10). With the same infarcted rat heart model, the purpose of the present study was to test whether beta-blocker treatment with bisoprolol prevents CK and lactate dehydrogenase system changes. In addition, we tested late treatment versus early treatment after myocardial infarction.
Methrjds
Animals aad experimental q yocardial infarction. Left anterior descending coronary artery ligations were induced in 12-week old male Wistar rate 1s previously described (11). A left thoracotomy was performed under ether anesthesia and positive pressure ventilation. The heart was rapidly exteriorized by applying gentle pressure on both sides of the thorax. The left anterior descending coronary artery was ligated between the pulmonary artery outflow tract and the left atrium. After replacement of the heart into the thorax, the lungs were intlated by increasing positive end-expiratory pressure, and the wound was closed immediately. Sham operations were performe" A using an identical procedure, except that the suture was passed under the coronary artery without ligation. For the first 24 h, the postoperative mortality rate of infarct gmup was 40% to 50%. The surviving rats were kept on standard rat chob, and water ad libitum. All procedures conformed to the guiding principles of the American Physiological Society.
Study groups. Preliminary experiments were performed to find a k dynamically effective dose for beta-blocker treatment: 6G +/kg body weight per day in drinking water decreased ' art rate in vivo from 402 t 24 beats/min (mean 2 SE) in untreated rats (n = 5) to 321 t-25 beatslmin in bisoprolol-treated rats (n = 5, p < 0.05). Smaller dosages did not reduce heart rate significantly.
Six groups of rats were studied: untreated rats with sham operation (sham) or left anterior descending coronary artery ligation (myocardial infarction), sham or myocardial infarction rats treated with bisoprolol starting 30 min after infarction (sham B and myocardial infarction B) and sham and myocardial infarction rats in which bisoprolol treatment started 14 days after infarction (sham 14 d B and myocardial infarction 14 d B). During the following 8 weeks, one untreated rat, one rat from the early treatment group and three from the late treatment group died. Thus, 8 weeks postoperatively, we studied 11 untreated sham and 13 untreated myocardial infarction rats, 12 late-treated sham and I3 late-treated myocardial, infarction rats and 9 early-treated sham and 14 early-treated myocardial infarction hearts, Bisoprolol treatment was stopped 1 day before isolating the heart to exclude effects of acute beta-blockade on our measurements. Bisoprolol is known to have an elimination half-life of 9 to 12 h (12).
1s@&d rat heart prepamtIon. Rats were anesthetized 8 weeks after idadOn by injection of 20 mg pentobrbital sodium &aperitoneally. A transverse laparotomy and a left and a right antemlateral thoracotomy were performed. The heart w6s rapid@ excised and immersed in ice-cold bulfer. At a coilatant temperature of 37"C, retrograde perfusion of the JACC Vol. 27. No. 2 February 1996%37-93 heart via the aorta was started in the LangendorE mode at a constant coronary perfusion pressure of 100 mm Hg. KrebsHenseleit buffer of the following composition was used (in mmol/liter): sodium chloride 118.0, potassium dihydrogen phosphate 1.2,' potassium chloride 4.7, magnesium sulfate 1.2, calcium chloride 1.75, disodium EDTA 0.5, glucose 11.0, sodium bicarbonate 25.0. Buffer was freshly made each day and was equilibrated with 95% oxygen + 5% carbon dioxide, yielding a pH of 7.4. The root of the pulmonary artery was cut open to allow for righ: ventricular outflow. The Row of the Thebesian veins was drained with a small polyethylene tubing pierced through the apex of the left ventricle. The heart was surrounded by its own pcrfusate in a water-jacketed reservoir. The perfusate level was kept constant immediately above the pulmonary outflow tract by continuous suction.
Cardiac performance measurements. A water-filled latex balloon was inserted into the left ventricle through an incision in the left atrium and was secured by a ligature. The balloon was connected to a Statham P23Db pressure transducer (Gould Instruments) by a small-bore stainless-steel tube. By varying the filling volume of the balloon, an end-diastolic pressure of 10 mm Hg was set; left ventricular pressure and heart rate were continuously recorded on an eight-channel recorder (Polygraph, ZAK).
Determination of infarct size. Because tissue was needed for biochemical measurements, the heart was separated into atria, right ventricle, left ventricular free wall, septum and scar after performance measurements. Each part was weighed. A sample of about 100 mg of intact left ventricular wall was taken for biochemical measurements. Infarcted hearts with a scar weight less than 200 mg were excluded. Each piece of scar was flattened between two glass plates. Photographs were taken with millimeter paper as background to determine scar area. Left ventricular volume was used to calculate left ventricular surface area. Infarct size was calculated as the percent of scar area in surface area. This method was previously shown to correlate closely with infarct size determined by standard morphologic techniques (13) .
High performance tiquid chrorsatagraphic measuremeats. Tissue was homogenized in 0.42 m3l/liter perchloric acid using the Potter S homogenizer (B. Brawn Melsungen AG), keeping the sample temperature at 4°C. After aliquots for protein measurements (14) were taken, 1 nol/liter potassium hydroxide was added to set a PH of about 5. The sample was centrifuged, fiitered and Injected into the high performance liquid chromatographic (XPLC) sptem for determination of total creatine. The HPLC system consisted of a pump (Waters Model 590, Millipore GmbH), an automatic injection system (Waters 712 WISP, Millipore GmbH). a spectrophotometer (Waters 486 Tunable Absorb:mce Detector, Millipore GmbH), a recorder (Waters 740 Data Module, MiNipore GmbH) and a reversed-phase column (Supelcosil LC-18.15.0 cm x 4.6 mm, S~pelco Deutschland GmbH). The 2cm guard column had the same stationary phase as the HPLC column: spherical 5-pm particles on a silica core with C-18 coating. The chromatography was run at room temperature and the wavelength of the Enzyme measorements. Each sample (5 to 10 mg of tissue) was homogenized in 0.1 mot/liter phosphate buffer, pH 7.4, containing 1 mmoifliter EGTA and 1 mmohliter betamercaptoethanoi. Before 0.1% Triton X was added, aiiquots for measurement of protein were taken. Ail samples were kept on ice. The following enzyme activities were measured using an Uitraspec III spectrophotometer (Pharmacia Biosystems): CK (16) lactate dehydrogenase (17) and citrate synthase (18). The isoenzymes of lactate dehydrogenase were determined with the Titan Gel LD isoenzyme System (Helena Diagnostika GmbH) using agarose gel eiectrophoresis. To measure the CK isoenzyme distribution, the Rapid Eiectrophoresis System (REP, Helena Diagnostika GmbH) was used as separation unit, and the REP CK &forms kit (Helena Diagnostika GmbH) for agarose gel and incubation solution were used. The agarose pi contams a Tris/barbitai buffer with sodium azide as preservative. The Eiectrophoresis Data Center (EDC, Helena Diagnostika GmbH) automatically quantified the separated isoenzyme bands.
Statistical groups. Infarcted rats in the eariy-treated group showed reduced body weights (518 + 14 vs. 446 L 14 g p < 0.05, myocardiai infarction vs. myocardiai infarction B) and reduced left ventricular weights (1.10 -C 0.05 vs. 0.92 2 0.04 g. p < 0.05, myocardiai infarction vs. myocardiai infxction B). but no significant differences occurred in the ratio of left ventricular weight to body weight among groups.
Pelfolmance of bEalted and astreated tntati hearts. Table 2 shows performance data from treated and untreated infarcted hearts under control conditions at an enddiastolic pressure of 10 mm Hg. Left ventricular developed pressure was significantly redxxd in untreated hearts after myucardiat infarction (120 + 9 vs. 104 -C 5 mm Hg p < 0.05, sham vs. myocardial imarction). This decrease of mechanical function was prevented by early (118 t 9 vs. 113 i 4 mm Hg, sham vs. myocardiai infarction) but not by late bisoprolol therapy (119 2 7 vs. 105 2 6 mm Hg, p < 0.05. sham vs. myocardiai infarction). Bisoproioi treatment was stopped 1 day befors isolating the heart to avoid acute effects of beta-blocker treatment, and heart rate did not differ among the various grow Creatine lriense system. Creatine kinase activity of intact left ventricuiar tissue was reduced after infarction (6.4 f 03 vs. 5.1 t 0.2 IU/mg protein. p < 0.05, Fig. 1A ). Bisoproloi treatment starting early preserved total CK activity at normal levels in infarcted !rearts. whereas late treatment failed to prevent the decrease in CKactivity. The relative dtstriiticm of the four CK isoenzymes BB, MB, MM and mit~ochondriai CK (mito-CK) changed after myocardiai infarction (Fig. 1, B to E) . The increase in the percentage of the BB isoenzyme ,$ter myocardiai infarction in untreated hearts (2.2 t 03% vs. 5.1 2 0.4%, p < 0.05. sham vs. myecardiai in&tion) was reduced in the late treatment group to 3.3% and in the early treatment group of 2.4%. Similar changes were found for the MB &enzyme: Bisoproloi reduced the increase of the MB isoenzyme completely (early treatment) or partially (late treatment). The MM percentage did not change in ail groups.' The sign&ant decrease of mit+CK after infarc=ion (34.8 2A-E). The activity of citrate synthase (IU/mg protein), a After myocardial infarction, t&al ereatine content (Fig. 1F) marker enzyme for mitochondriai mass, was comparable for all decreased (74. ratio of left ventricular weight to body weight is only a crude 78 t 0.7, p < 0.05) increased signilicantly after myocardial measure for hypertrophy and does not necessarily reflect the infarction. This was completely prevented by early treatment inhomogeneous changes at the cellular level. Previous studies using the same rat infarct model have suggested that betaafter long-term Lk%Alockade (71). In tbil latter t,udv hablocker treatment blunts hypertrophy but promotes left venblocker treatment was started 3 weeks after coronary l.:.&on. tricular dilation at the same time (20, 21) , with a net result of similar to the late-treatment protocol in the presen study. unchanged left ventricular weight after beta-blockade in inwhich did not prevent deterioration of left ventricular perforfarcted hearts. Thus, bisoprobl may have bad effects on mance. Thus. the conflicting results may in part be explained morphology not reflected in the present study.
by the digerent treatment regimens (early vs. late).
Mecbaoieal Bmctinn. Only limited data have been preCreathK kinase aad laetnte dehy&ugen~ systems. The sented on functional effects of beta-blockade on surviving major result of the present study was that bboprolol treatment myocardium after myocardial infarction. Our data support the prevented an increase in the anaerobii lactate dehydrogenase hypothesis that long-term beta-blocker treatment started early &forms, the shift toward the fetal CR isoenzymes BB and MB after myocardial infarction may in part prevent deterioration and the depletion of creatine, which we previously dexribed of mechanical function. Clearly, using developed pressure in a atier myocardial infarction (IO). During development from Langendorif preparation to measure left ventricular function fetal to adult myocardium. total CK actMy and mito-CK has limitations. Loading conditions in vivo may be quite increase. whereas the fetal isoenzymes BB amt MB decrease different, and geometric changes of the heart will greatfy (22) . The increase in fetal isoenzymes BB and MB is a uniform influence left ventricular function (13) . Long-term betastress ttqcme observed after chronic coronary artery occh~-adrenergic blockade improved basal isometric contraction in sion in the dog (23) . in rat and dog facing pressure or volume noninfarcted isolated papillary muscle in rats after myocardial overload or hypertension (24) (25) (26) and in myocardium of infarction. a model that eliminates the influence of geometric patients with vafvular aortic stenosis or coronary tirtery disease chenges of left ventricle (3). Although these investigators (27) . This isoenzyrue shift was interpreted as an adaptive founds an up-regulation of beta-adrenoreceptor density after mechanism, because the adinity of the fetal B-tlrpe hoenzymes propranolol treatment, it is unlikely to be the reason for for creatine phosphate is higher than the afftnity of the MM improved mechanical performar~~ because adenyfate cydase iswnzyme, making the phosphoryf tramkr hrn creatine activity was still impaired (3) . Med&cal function measured phosphate to &xtosine triphosphate (ATP) more efhcient. In in vivo in rats post-myocatdhd infarction was not improved the failing myocardium of I8-month old spontaneously hyper-BETA-BLOCKADE AND ENZYME CHANGES tensive rat, reductions of total CK activity, mito-CK and total creatine occur in addition (24) . Increases of anaerobic lactate dehydrogenase were also described in biopsy samples of patients with severe chronic heart failure (28).
rate. Either one would be important, however, and the data suggest so far unknown effects on beta-blockade in chronic cardiac dysfunction.
Effects of beta-blockade on hypertrophy and on the adrenergic sysiem might prevent these CK and lactate dehydrogenase changes. Chronic tissue hypoxia may be a possible trigger mechanism (27) or high serum catecholamine levels (29) . In addition, beta-blocker treatment might have an energetically favorable effect by chronically reducing heart rate, rendering the adaptive increase of CK and lactate dehydrogenase isoforms unnecessary. Clearly, further studies are required to address the mechanism and the importance for myocardial function of this beta-blocker effect. The lactate dehydrogenase system changes are unlikely to be of significance for myocardial function, because lactate dehydrogenase is not a rate-limiting enzyme in the glycolytic pathway. This may, however. indicate prevention of a shift tc chronic anaerobic metabolism.
What might be the potential consequence of preservation of myocardial creatine in surviving myocardium after myocardial infarction? Because the ratio of phosphotylated to unphosphorylated creatine remains constant under all but acutely ischcmic or hypoxic conditions, supplementation of intracellular creatine might preserve phosphotylated creatine and energy reserve in the surviving myocardium. However, the effect of beta-blockade on phosphocreatine has not been measured. In patients with severe dilated cardiomyopathy, creatine phosphate/ATF' ratios measured by phosphorus-31 magnetic resonance spectroscopy increased to normal levels during clinical recompensation with treatment with digitalis, diuretic drugs, angiotensin-converting enzyme inhibitors and the beta-blocker metoprolol (34) . It remains unc!ear whether energy metabolism changes were primary or secondary to hemodynamic improvement. Beta-blocker therapy may improve mechanical work without an increase in oxygen consumption in patients with severe heart failure (5,35). Thus, reduction of energetic costs of cardiac performance by beta-blockade may also contribute to preservation of energy reserve. At this point it remains speculative whether longterm beta-blocker treatment has direct e5ccts on creatine transport and metabolism and myocardial enzymes or whether these changes are secondary, for instance, to a reduced heart
